Correlation Between Iteos Therapeutics and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Kymera Therapeutics, you can compare the effects of market volatilities on Iteos Therapeutics and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Kymera Therapeutics.
Diversification Opportunities for Iteos Therapeutics and Kymera Therapeutics
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Iteos and Kymera is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and Kymera Therapeutics
Given the investment horizon of 90 days Iteos Therapeutics is expected to generate 0.87 times more return on investment than Kymera Therapeutics. However, Iteos Therapeutics is 1.15 times less risky than Kymera Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 860.00 in Iteos Therapeutics on August 25, 2024 and sell it today you would lose (28.00) from holding Iteos Therapeutics or give up 3.26% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Iteos Therapeutics vs. Kymera Therapeutics
Performance |
Timeline |
Iteos Therapeutics |
Kymera Therapeutics |
Iteos Therapeutics and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iteos Therapeutics and Kymera Therapeutics
The main advantage of trading using opposite Iteos Therapeutics and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |